Vito Quaranta Archives
Research excellence honored
Aug. 15, 2019—Graduate student Christian Meyer recently received the 2019 Richard Armstrong Prize for Research Excellence.
$8.1 million grant funds new center to research highly aggressive form of lung cancer
Jun. 8, 2018—A five-year National Cancer Institute grant will fund an interdisciplinary research center for the study of small cell lung cancer, a highly aggressive, incurable form of the disease.
“Idling” cancer cells may return
Apr. 11, 2018—Vanderbilt investigators have discovered that cancer treatment induces an “idling” state for cells, which could promote resistance to treatment.
Melanoma study finds new way to enhance targeted therapies
Mar. 9, 2017—With the help of a drug formerly used to treat HIV/AIDS, researchers at Vanderbilt University Medical Center (VUMC) have found a way to make melanoma cells more vulnerable to targeted anti-cancer therapy.
Current cancer drug discovery method flawed: VUMC study
May. 5, 2016—The primary method used to test compounds for anti-cancer activity in cells is flawed, Vanderbilt University researchers reported May 2 in Nature Methods.
Ten Vanderbilt faculty members elected AAAS fellows
Nov. 23, 2015—Ten members of Vanderbilt University’s faculty have been elected fellows of the American Association for the Advancement of Science.
Method may refine personalized trials for cancer therapy
Aug. 16, 2012—A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy, and may offer a way to further refine personalized cancer treatments.
Protein ‘scissors’ cut path for cancer
Feb. 22, 2011—The protein matriptase "cuts" a key component of the prostate tissue barrier and may be involved in prostrate cancer progression, new research finds.
